Steroid sensitive nephrotic syndrome: revised guidelines

A Sinha, A Bagga, S Banerjee, K Mishra… - Asian Journal of …, 2021 - journals.lww.com
Objective: To frame revised guidelines on diagnosis, evaluation, management, and
supportive care of patients with the illness. Process: The guidelines combine evidence …

Indian Academy of Pediatrics Revised (2021) guidelines on prevention and treatment of vitamin D deficiency and rickets

P Gupta, A Dabas, A Seth, VL Bhatia, R Khadgawat… - Indian Pediatrics, 2022 - Springer
Justification The emerging literature on prevalence of vitamin D deficiency in India,
prevention and treatment strategies of rickets, and extra-skeletal benefits of vitamin D …

Therapeutic drug monitoring in childhood idiopathic nephrotic syndrome: a state of the art review

FF Lai, EY Chan, K Tullus, AL Ma - Pediatric Nephrology, 2024 - Springer
Immunosuppressants are commonly used as steroid-sparing agents in childhood idiopathic
nephrotic syndrome (NS) to induce and sustain remissions. These drugs have narrow …

Sequential rituximab therapy sustains remission of nephrotic syndrome but carries high risk of adverse effects

A Sinha, G Mathew, A Arushi… - Nephrology Dialysis …, 2023 - academic.oup.com
Background Sequential rituximab (RTX) administration has emerged as an important
strategy to sustain remission of disease in patients with difficult-to-treat nephrotic syndrome …

Clinical practice guidelines for nephrotic syndrome: consensus is emerging

A Sinha, A Bagga - Pediatric Nephrology, 2022 - Springer
Nephrotic syndrome is one of the most common chronic kidney diseases (CKD) in children
with an estimated incidence of 2.92 (range 1.15–16.9) per 100,000 children per year [1]. The …

Kidney outcomes in children with primary focal segmental glomerulosclerosis from a low-and middle-income country

K Priyanka, B Deepthi, S Krishnasamy, RN Ganesh… - Pediatric …, 2024 - Springer
Background Limited data exists regarding the clinical course and outcomes of children with
primary focal segmental glomerulosclerosis (FSGS) from low-and middle-income countries …

Intravenous cyclophosphamide therapy in children with calcineurin inhibitor-resistant steroid-resistant nephrotic syndrome in a resource-limited setting

P Saiteja, B Deepthi, S Krishnasamy, M Sravani… - Pediatric …, 2024 - Springer
Background In pediatric steroid-resistant nephrotic syndrome (SRNS), calcineurin inhibitors
(CNIs) are recommended as first-line therapy, with efficacy ranging between 60 and 80 …

Prospective population pharmacokinetic study of tacrolimus in adult recipients early after liver transplantation: A comparison of Michaelis-Menten and theory-based …

XJ Cai, RD Li, JH Li, YF Tao, QB Zhang… - Frontiers in …, 2022 - frontiersin.org
Background and Objective: Tacrolimus, a calcineurin inhibitor widely used as a potent
immunosuppressant to prevent graft rejection, exhibits nonlinear kinetics in patients with …

Management of focal segmental glomerulosclerosis in resource-limited regions

S Banerjee, M Bonilla-Felix - Pediatric Nephrology, 2024 - Springer
The management of focal segmental glomerulosclerosis (FSGS) is challenging, and a
definitive long-term cure remains elusive. It is associated with poor outcomes due to …

Incidence and predictive risk factors for ophthalmological complications in children with nephrotic syndrome receiving long-term oral corticosteroids: a cohort study

R Hariharan, S Krishnamurthy… - Paediatrics and …, 2021 - Taylor & Francis
Background There is a paucity of data from India on ophthalmological complications in
children on long-term oral corticosteroids for idiopathic nephrotic syndrome. Methods All …